ERBB2 and breast cancer: Another example is the anti-HER2 mAb trastuzumab, which has been used in combination with IL-12 in treating patients with recurrent solid tumors [breast cancer, endometrial carcinoma, gastric cancer, non-small cell lung cancer (NSCLC), SCLC, and ovarian epithelial cancer] (NCT00028535).